Stock listing

KRX:039200 Oscotec Inc. (오스코텍) 주가

Follow Oscotec Inc. into a list and get an email when it puts out news.

Share price · KRX:039200

₩31,650 KRW -650 (-2.0%)

Close on Nov 20, 2026

Past year -41.7% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
₩31,400 – ₩32,500 KRWNov 20, 2026
Volume
71,620 sharesNov 20, 2026
Market cap
₩889.4B KRWAt the close on Nov 20, 2026 · price × 28.10M shares outstanding
52-week range
₩27,300 – ₩66,000 KRWLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
₩4.43B KRWMedian day 111,103 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Oscotec Inc. logo

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · KRX:039200 · KRW, adjusted for splits

DayCloseChange%OpenHighLowVolume
₩31,650-650-2.0%₩32,000₩32,500₩31,40071,620
₩32,300-450-1.4%₩32,950₩34,000₩32,050119,739
₩32,750-1,500-4.4%₩34,100₩34,750₩32,700139,342
₩34,250-1,550-4.3%₩36,500₩36,700₩34,25092,548
₩35,800+100+0.3%₩36,200₩38,300₩35,750152,332
₩35,700-1,800-4.8%₩37,150₩38,150₩35,50092,055
₩37,500+1,450+4.0%₩36,000₩38,100₩35,90093,980
₩36,050-100-0.3%₩37,100₩37,950₩35,700107,156
₩36,150-150-0.4%₩36,000₩37,850₩35,450121,079
₩36,300-1,200-3.2%₩36,150₩39,450₩34,000230,658
₩37,500+650+1.8%₩37,750₩39,250₩37,100231,784
₩36,850+1,450+4.1%₩35,450₩36,900₩34,250149,548
₩35,40000.0%₩34,450₩35,500₩34,100101,397
₩35,400-1,050-2.9%₩36,450₩36,450₩35,25071,764
₩36,450-50-0.1%₩36,350₩36,800₩35,300122,955
₩36,500-150-0.4%₩37,200₩37,200₩35,85095,414
₩36,650+750+2.1%₩36,000₩37,400₩36,00082,427
₩35,900-100-0.3%₩36,350₩37,450₩35,700122,139
₩36,000-1,250-3.4%₩36,750₩37,250₩36,00060,537
₩37,250-250-0.7%₩37,350₩38,000₩36,65093,792
₩37,500-300-0.8%₩37,550₩38,500₩36,850103,609
₩37,800+300+0.8%₩38,250₩39,500₩37,600122,487
₩37,500-800-2.1%₩37,700₩39,350₩36,900276,842
₩38,300+1,600+4.4%₩36,700₩38,550₩36,150195,116
₩36,700+1,950+5.6%₩34,650₩38,250₩34,650207,123
₩34,750-1,050-2.9%₩35,000₩35,400₩34,15097,900
₩35,800+450+1.3%₩35,000₩36,550₩34,95098,066
₩35,350-1,150-3.2%₩36,400₩36,400₩34,600110,874
₩36,500-1,200-3.2%₩37,600₩37,850₩36,30077,284
₩37,700-2,000-5.0%₩39,500₩39,950₩37,400120,779
₩39,700+550+1.4%₩39,200₩40,850₩39,200149,742
₩39,150+2,550+7.0%₩36,600₩39,250₩36,450180,041
₩36,600-1,400-3.7%₩38,350₩38,550₩36,150114,016
₩38,000+2,350+6.6%₩35,400₩38,000₩35,150180,025
₩35,65000.0%₩35,900₩36,150₩35,30073,453
₩35,650+400+1.1%₩35,150₩35,800₩34,300111,332
₩35,250-550-1.5%₩36,200₩36,800₩35,05084,506
₩35,800-400-1.1%₩36,100₩36,700₩35,30074,922
₩36,200+350+1.0%₩36,200₩37,000₩35,95068,511
₩35,850-700-1.9%₩36,700₩37,700₩35,70080,459
₩36,550-900-2.4%₩37,600₩37,600₩36,300127,091
₩37,450+3,100+9.0%₩34,700₩37,600₩34,700223,870
₩34,350-250-0.7%₩34,350₩34,650₩33,95044,157
₩34,60000.0%₩34,850₩35,600₩34,50085,918
₩34,600-300-0.9%₩33,500₩35,000₩33,45065,258
₩34,900-550-1.6%₩34,300₩35,200₩34,30074,822
₩35,450+650+1.9%₩34,100₩35,450₩33,650114,415
₩34,800-250-0.7%₩34,650₩35,600₩34,60088,800
₩35,050-900-2.5%₩35,800₩36,100₩35,05084,729
₩35,950-650-1.8%₩36,600₩37,050₩35,750108,920
₩36,600+700+1.9%₩36,100₩37,000₩35,400152,390
₩35,900-700-1.9%₩36,950₩37,100₩35,60076,905
₩36,600-400-1.1%₩36,200₩37,550₩35,800133,075
₩37,000+1,950+5.6%₩35,150₩37,200₩35,150161,788
₩35,050-750-2.1%₩35,000₩35,950₩34,500142,298
₩35,800+750+2.1%₩34,700₩35,950₩34,50068,039
₩35,050-850-2.4%₩35,500₩35,650₩33,900262,836
₩35,900-1,400-3.8%₩37,000₩38,150₩35,700106,760
₩37,300-950-2.5%₩37,800₩38,300₩35,850142,343
₩38,250+1,550+4.2%₩36,800₩38,800₩36,800133,762
₩36,700-2,150-5.5%₩37,900₩38,500₩35,900125,180
₩38,850+750+2.0%₩39,300₩40,000₩37,500153,061

Splits

3 splits since 2009 · KRX:039200 · every price before a split is adjusted for it

DayRatioWhat
89-for-82Split
2-for-1Split
38-for-37Split
Ticker
KRX:039200
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
KRX
Currency
KRW

Oscotec Inc. on 6ix

Sector
Health care
Industry
Biotechnology

Valuation

P/E 11.6× against a median of 2.7×: the highest of 4 Biotechnology companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
₩889.4B KRW
P/E
11.6×
EV/sales
6.3×
EV/EBITDA
No depreciation figure on 6ix yet
Price/book
4.5×
Gross margin
98.6%
Operating margin
67.9%
Net margin
54.0%
Debt to equity
0.0×
Beta
No index for this market yet

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Oscotec Inc. · KRX:039200US$660.8MUS$660.8M11.6×6.3×n/a4.5×54.0%0.0×n/a
Lexicon Pharmaceuticals, Inc. · NASDAQ:LXRXUS$681.2MUS$549.9Mn/a14.3×n/a4.2×−161.8%0.3×1.15
CARsgen Therapeutics Holdings Ltd. · HKEX:2171US$676.1MUS$476.8Mn/a25.3×n/a4.1×−77.9%0.1×n/a
Philogen SpA · MIL:PHILUS$672.3MUS$532.7M2.7×1.5×n/a1.6×71.8%0.0×n/a
Nuvectis Pharma, Inc. · NASDAQ:NVCTUS$666.8MUS$526.1Mn/an/an/a5.3×n/a0.0×0.84
Sun Pharma Advanced Research Co. Ltd. · NSE:SPARCUS$666.0MUS$519.1M3.8×2.5×2.9×4.3×84.7%0.0×n/a
Shouyao Holdings Beijing Co. Ltd. Class A · SSE:688197US$648.7MUS$566.3Mn/a37.8×n/a6.8×−18.6%0.0×n/a
Prime Medicine, Inc. · NASDAQ:PRMEUS$645.8MUS$695.1Mn/a98.4×n/a76.5×n/a13.1×2.28
Sagimet Biosciences Inc. - Series A · NASDAQ:SGMTUS$638.7MUS$404.3Mn/an/an/a2.6×n/a0.0×1.96
Gubra A/S · OMXCOP:GUBRAUS$638.5MUS$533.6M2.6×1.4×1.7×4.2×64.1%0.2×n/a
Kura Oncology, Inc. · NASDAQ:KURAUS$634.9MUS$152.6Mn/a1.9×n/a35.4×−369.3%0.6×1.30
Median of the othersUS$657.3MUS$529.4M2.7×8.4×2.3×4.2×−18.6%0.0×1.30

Forecasts

Analysts' consensus from EODHD, read Nov 20, 2026. Not 6ix's view and not investment advice.

Price target
75000.00 KRW · Analysts' mean
EPS, year to Dec 2026
841.00 · 1 analyst
Revenue, year to Dec 2026
84B · 1 analyst

Team and board

Officers

OfficerRole
Sanghyun LeeCurrent CEO, Oscotec Inc.
Taeyoung YoonCurrent CEO, Oscotec Inc.
Dongjun ShinCurrent Executive Vice President, Oscotec Inc.
Jinhyung KangCurrent Executive Vice President, Oscotec Inc.
Youngshin KwakCurrent Vice President, Oscotec Inc.

Board

DirectorRole
Dongjun ShinCurrent Executive Vice President, Oscotec Inc.
Jinhyung KangCurrent Executive Vice President, Oscotec Inc.
Kyungsup LeeCurrent Independent Director, Oscotec Inc.
Kyusik KimCurrent Independent Director, Oscotec Inc.
Sanghyun LeeCurrent CEO, Oscotec Inc.
Taeyoung YoonCurrent CEO, Oscotec Inc.
Youngshin KwakCurrent Vice President, Oscotec Inc.

Events

QuarterResultsShare move
Q3 2026Nov 18, 2026−3.4%
Q2 2026Aug 19, 2026+6.2%
Q1 2026May 13, 2026 · Before open−3.8%
Q4 2025Feb 25, 2026 · Before open−1.8%
Q3 2025Nov 11, 2025 · Before open−3.0%
Q2 2025Aug 12, 2025 · Before open+0.8%
Q1 2025May 14, 2025 · Before open+0.2%
Q4 2024Feb 26, 2025 · Before open+3.3%
Q3 2024Nov 12, 2024 · After close+0.4%
Q2 2024Aug 14, 2024 · After close+6.7%
All 20 quarters
QuarterResultsShare move
Q1 2024May 14, 2024 · After close+2.3%
Q4 2023Mar 18, 2024 · After close+0.2%
Q3 2023Nov 14, 2023 · After close+3.5%
Q2 2023Aug 14, 2023 · After close0.0%
Q1 2023May 12, 2023 · After close+1.6%
Q4 2022Mar 17, 2023 · Before open+2.2%
Q3 2022Nov 14, 2022 · Before open−0.6%
Q2 2022Aug 16, 2022 · Before open−2.7%
Q1 2022May 13, 2022 · Before open+1.4%
Q4 2021Mar 7, 2022−3.2%

Open Events

Financials

Annual, in KRW

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue99.8B34.0B4.95B5.06B3.90B43.5B4.37B18.7B3.91B3.55B
Cost of revenue1.95B2.23B2.03B2.02B1.95B1.89B2.09B2.44B1.69B1.50B
Gross profit97.9B31.8B2.92B3.04B1.95B41.6B2.27B16.3B2.22B2.06B
Research and development27.6B21.4B24.9B23.3B22.7B32.8B15.4B6.97B4.82B6.55B
Selling, general and administrative7.46B11.3B8.98B6.74B5.97B6.23B6.13B2.85B2.93B1.92B
Operating income52.1B-3.41B-32.7B-29.3B-29.1B1.36B-19.9B6.18B-3.66B-4.11B
Depreciation and amortization1.65B1.89B1.81B1.66B1.54B1.07B620.6M307.9M317.3M289.8M
EBITDA53.7B-1.52B-30.8B-27.6B-27.6B2.43B-19.3B6.49B-3.34B-3.82B
Interest expense2.27B1.09B406.6M316.4M107.6M709.2M1.08B000
Income before tax52.8B-1.12B-32.3B-28.0B-28.6B1.29B-22.7B5.20B-4.28B-4.91B
Income tax6.93M3.34B2.31B921.0M0-36.8M
Net income52.3B876.5M-24.3B-24.4B-26.3B-4.36B-22.4B3.47B-3.89B-3.65B
Earnings per share, basic1,368.1522.92-639.20-664.88-829.41-140.60-741.77119.24-137.92-137.27

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents15.2B13.1B7.95B53.0K10.6B5.79B49.2B26.4B19.7B3.17B
Short-term investments92.9B89.6B89.5B98.2B4.00B22.3B3.48B9.30B4.06B6.56B
Receivables87.6B34.8B1.79B1.61B599.2M24.6B765.7M19.2B3.91B5.65B
Inventory1.82B1.77B1.70B1.27B1.20B1.10B1.02B1.00B884.6M827.8M
Current assets199.0B141.2B102.4B107.9B17.0B55.0B55.3B57.3B29.5B17.5B
Property, plant and equipment18.1B19.1B23.2B12.8B15.5B11.5B9.49B8.44B
Total assets229.9B170.8B132.6B143.7B49.0B76.4B72.4B70.3B40.5B40.8B
Accounts payable60.4M20.4M895.6M705.6M310.2M315.2M202.8M355.7M94.4M110.1M
Current liabilities39.0B34.8B34.8B18.6B14.4B15.5B14.4B15.7B11.7B8.91B
Long-term debt0187.7M563.2M1.26B1.31B1.68B2.08B2.18B
Total debt1.31B2.42B3.75B5.09B5.32B
Total liabilities43.0B38.4B37.9B21.2B20.1B23.3B21.1B24.0B19.3B14.5B
Shareholders' equity181.3B127.8B98.9B122.5B28.8B53.1B51.3B46.3B21.2B26.3B
Shares outstanding38.3M38.2M38.0M36.7M31.7M31.0M30.2M29.1M28.2M26.6M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations8.30B-26.0B-22.0B-26.4B-8.76B-17.9B27.5M-5.08B-3.69B-8.21B
Capital spending-779.6M-691.9M-581.2M-1.25B-7.52B-5.22B-4.19B-1.72B-61.5M-7.08B
Free cash flow7.52B-26.7B-22.6B-27.7B-19.1B-23.1B-4.16B-6.80B-3.75B-15.3B
Cash from investing-327.7M13.4B-99.6B6.78B-24.4B1.77B-7.92B2.84B10.7B
Cash from financing30.3B11.1B120.3B6.26B-1.01B20.8B19.3B17.9B-1.33B
Share buybacks6.58B9.51B117.4B728.0M14.8K480.1M228.8M7.22B-1.43B
Change in cash2.09B5.15B2.43B-5.06B4.79B-43.4B22.9B6.66B16.4B1.18B

Open Financials

Cap table

Built by 6ix from Oscotec Inc.’s releases

Common shares
28,101,800
Fully diluted
28,101,800

Fully diluted

LineShares
Common shares28,101,800

Share count over time

CountShares
Nov 22, 202628,101,800

Open Cap table

Shareholders

HolderSharesValueAs of
Vanguard Total International Stock Index Fund417KUS$8.74MJul 31, 2026
iShares Core MSCI Emerging Markets ETF398KUS$11.1MMay 31, 2026
Vanguard Developed Markets Index Fund275KUS$6.47MJun 30, 2026
Vanguard Ftse All-World Ex-Us Small-Cap Index Fund106KUS$2.22MJul 31, 2026
iShares Core MSCI Total International Stock ETF71,702US$1.5MJul 31, 2026
Schwab International Small-Cap Equity ETF68,777US$1.92MMay 31, 2026
The Emerging Markets Small Cap Series48,048US$1.01MJul 31, 2026
Vanguard Pacific Stock Index Fund30,437US$637KJul 31, 2026
State Street(R) SPDR(R) Portfolio Developed World ex-US ETF30,238US$707KJun 30, 2026
Vanguard Total World Stock Index Fund23,776US$498KJul 31, 2026
All 26 holders
HolderSharesValueAs of
Dimensional Emerging Markets Core Equity 2 ETF22,977US$484KJul 31, 2026
College Retirement Equities Fund - Total Global Stock Account22,133US$520KJun 30, 2026
Fidelity Total International Index Fund18,770US$388KJul 31, 2026
State Street(R) SPDR(R) S&P(R) International Small Cap ETF15,313US$358KJun 30, 2026
Dimensional Emerging Core Equity Market ETF12,473US$263KJul 31, 2026
iShares MSCI Emerging Markets Small-Cap ETF7,574US$211KMay 31, 2026
Vanguard ESG International Stock ETF7,197US$201KMay 31, 2026
World ex U.S. Core Equity Portfolio7,105US$149KJul 31, 2026
State Street Global All Cap Equity ex-U.S. Index Portfolio5,686US$133KJun 30, 2026
Emerging Markets ex China Core Equity Portfolio3,637US$76,159Jul 31, 2026
Dimensional World ex. U.S. Core Equity 2 ETF1,888US$39,794Jul 31, 2026
Emerging Markets Social Core Equity Portfolio1,813US$37,964Jul 31, 2026
State Street(R) SPDR(R) Portfolio MSCI Global Stock Market ETF1,312US$30,698Jun 30, 2026
Dimensional Emerging Markets Sustainability Core 1 ETF1,198US$25,251Jul 31, 2026
FlexShares Morningstar Emerging Markets Factor Tilt Index Fund855US$18,021Jul 31, 2026
Avantis Emerging Markets Equity ETF202US$5,628May 31, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Dongjun ShinCurrent Executive Vice President, Oscotec Inc. · Since at least Nov 5, 2026
Jinhyung KangCurrent Executive Vice President, Oscotec Inc. · Since at least Nov 5, 2026
Kyungsup LeeCurrent Independent Director, Oscotec Inc. · Since at least Nov 5, 2026
Kyusik KimCurrent Independent Director, Oscotec Inc. · Since at least Nov 5, 2026
Sanghyun LeeCurrent CEO, Oscotec Inc. · Since at least Nov 5, 2026
Taeyoung YoonCurrent CEO, Oscotec Inc. · Since at least Nov 5, 2026
Youngshin KwakCurrent Vice President, Oscotec Inc. · Since at least Nov 5, 2026

Open People

Log in to ask 6ix AI your own questions about Oscotec Inc.